Technical Analysis for OHRP - Ohr Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 2.43 2.97% 0.07
OHRP closed up 2.97 percent on Monday, March 18, 2019, on 43 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical OHRP trend table...

Date Alert Name Type % Chg
Mar 18 20 DMA Support Bullish 0.00%
Mar 18 Crossed Above 50 DMA Bullish 0.00%
Mar 18 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 18 Narrow Range Bar Range Contraction 0.00%
Mar 18 Inside Day Range Contraction 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 50 DMA Resistance Bearish 2.97%
Mar 15 20 DMA Support Bullish 2.97%

Older signals for OHRP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
OHR Pharmaceutical, Inc. operates as a biotechnology company. The company's product line includes Squalamine, an anti-angiogenic small molecule with a novel intracellular mechanism of action that inhibits vascular endothelial, platelet derived and basic fibroblast growth factors for the treatment of the wet form of age-related macular degeneration. It also offers OHR/AVR 118, which is in Phase II clinical trial for the treatment of cancer cachexia, a multi-symptom wasting disorder characterized by weight loss, muscle atrophy, fatigue, weakness, and significant loss of appetite. The company is headquartered in New York, New York.
Medicine Biotechnology Cancer Medical Specialties Treatment Of Cancer Age Related Macular Degeneration Rehabilitation Medicine Angiology Disorder Cachexia
Is OHRP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.6
52 Week Low 1.6
Average Volume 264,993
200-Day Moving Average 3.4384
50-Day Moving Average 2.3921
20-Day Moving Average 2.3025
10-Day Moving Average 2.489
Average True Range 0.4032
ADX 39.88
+DI 35.0667
-DI 14.1098
Chandelier Exit (Long, 3 ATRs ) 3.11
Chandelier Exit (Short, 3 ATRs ) 3.0596
Upper Bollinger Band 2.8673
Lower Bollinger Band 1.7377
Percent B (%b) 0.61
BandWidth 49.059718
MACD Line 0.032
MACD Signal Line 0.0225
MACD Histogram 0.0096
Fundamentals Value
Market Cap 136.61 Million
Num Shares 56.2 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -3.73
Price-to-Sales 0.00
Price-to-Book 1.30
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.69
Resistance 3 (R3) 2.67 2.56 2.65
Resistance 2 (R2) 2.56 2.50 2.57 2.63
Resistance 1 (R1) 2.50 2.46 2.53 2.52 2.62
Pivot Point 2.39 2.39 2.41 2.40 2.39
Support 1 (S1) 2.32 2.32 2.36 2.34 2.24
Support 2 (S2) 2.22 2.28 2.23 2.23
Support 3 (S3) 2.15 2.22 2.21
Support 4 (S4) 2.17